Literature DB >> 11224637

Diagnosis and treatment of pediatric viral myocarditis.

D Levi1, J Alejos.   

Abstract

Acute myocarditis is characterized by the rapid development of life-threatening congestive heart failure and arrhythmias. Although the initial stages of this disorder apparently result from direct cytopathic effects on the atrial and ventricular myocardium, later stages of progressive decompensation may result from immune-mediated myocyte destruction. There has been recent improvement in understanding the role of this immunologic cascade. As a result, treatment now begins earlier in the course of the disease and can target both the virus and the immune response. Our ability to implement mechanical support in children as a bridge to transplant or recovery, even in children presenting in the final stages of their disease, has led to an improved outcome regarding morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11224637     DOI: 10.1097/00001573-200103000-00001

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  15 in total

1.  Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Cytokine Balance in Mice.

Authors:  Shouxin Zhang; Xiaoyan Liu; Chengming Sun; Jun Yang; Lihong Wang; Jie Liu; Lei Gong; Yanyan Jing
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

2.  Short-term outcomes of acute fulminant myocarditis in children.

Authors:  Jhuma Sankar; Sumaira Khalil; M Jeeva Sankar; Dinesh Kumar; Nandkishore Dubey
Journal:  Pediatr Cardiol       Date:  2011-05-17       Impact factor: 1.655

Review 3.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

4.  Lethal influenza B myocarditis in a child and review of the literature for pediatric age groups.

Authors:  H Frank; C Wittekind; U G Liebert; M Siekmeyer; W Siekmeyer; V Schuster; W Kiess
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

5.  Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children.

Authors:  J Soongswang; K Durongpisitkul; A Nana; D Laohaprasittiporn; C Kangkagate; K Punlee; N Limpimwong
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

6.  Favorable outcome of pediatric fulminant myocarditis supported by extracorporeal membranous oxygenation.

Authors:  Elhanan Nahum; Ovdi Dagan; Amiram Lev; Golan Shukrun; Gabriel Amir; George Frenkel; Jacob Katz; Berant Michel; Einat Birk
Journal:  Pediatr Cardiol       Date:  2010-08-24       Impact factor: 1.655

Review 7.  Fulminant myocarditis associated with the H1N1 influenza virus: case report and literature review.

Authors:  Maria Lúcia Saraiva Lobo; Ângela Taguchi; Heloísa Amaral Gaspar; Juliana Ferreira Ferranti; Werther Brunow de Carvalho; Artur Figueiredo Delgado
Journal:  Rev Bras Ter Intensiva       Date:  2014 Jul-Sep

8.  Outcome of acute fulminant myocarditis in children.

Authors:  N Amabile; A Fraisse; J Bouvenot; P Chetaille; C Ovaert
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

9.  Muronomab-CD3 for pediatric acute myocarditis.

Authors:  Gregory Perens; Daniel S Levi; Juan Carlos Alejos; Glenn T Wetzel
Journal:  Pediatr Cardiol       Date:  2006-12-07       Impact factor: 1.655

10.  Use of intravenous immunoglobulin compared with standard therapy is associated with improved clinical outcomes in children with acute encephalitis syndrome complicated by myocarditis.

Authors:  Girish Chandra Bhatt; Jhuma Sankar; K P Kushwaha
Journal:  Pediatr Cardiol       Date:  2012-05-16       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.